Search Results
Jul 10, 2025, 08:00 ET Transcend Therapeutics Receives Breakthrough Therapy Designation for TSND-201 (methylone) for the Treatment of PTSD
Therapeutics. TSND-201 has well-characterized primary pharmacology, with its primary site of action at the monoamine transporters, and no activity at 5HT-2a (i.e., not hallucinogenic). Transcend is developing TSND-201 as a rapid-acting and durable treatment for PTSD and other central nervous system (CNS)
More news about: Transcend Therapeutics
Jul 08, 2025, 08:00 ET Supplemental new drug application submitted to U.S. FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo
in neuropsychiatric disorders." While its exact mechanism of action is unknown, CAPLYTA® is characterized by high serotonin 5-HT2A receptor occupancy and lower amounts of dopamine D2 receptor occupancy at therapeutic doses. In short-term clinical studies, CAPLYTA® was
More news about: Johnson & Johnson
Jun 26, 2025, 15:00 ET Ultima Genomics Selected to Support the World's Largest Proteomics Studies to Date Led by Regeneron Genetics Center
"These RGC proteomics studies build on the growing momentum we are seeing..."For these efforts, RGC will utilize the Olink Explore HT platform and Ultima's UG 100 platform. Ultima's technology was selected for its scalability, efficiency, and suitability for large population-level studies
More news about: Ultima Genomics
Jun 24, 2025, 18:56 ET GAC Alcança "Plano de Ação Brasil", Construindo uma Marca Automotiva Confiável para os Consumidores Brasileiros
e às tendências de transição verde do Brasil. Enquanto isso, a GAC apresentou cinco modelos para os consumidores brasileiros: AION V, AION Y, HYPTEC HT, GS4 HEV e AION ES no evento. Esses cinco novos modelos incorporam os principais pontos fortes da GAC de "Qualidade de primeira linha" e "Tecnologia pioneira",
More news about: GAC
Jun 24, 2025, 10:49 ET AISWEI brille à SNEC avec des solutions pionnières
rythme du temps. En ce qui concerne les centrales électriques à grande échelle, AISWEI a présenté le PV inverter ASW 250-360kW HT series triphasé de la série HT. Ce produit est équipé des dernières réalisations technologiques d'AISWEI au cours des dernières années et est en avance sur les produits
More news about: AISWEI Technology Co., Ltd
Jun 24, 2025, 10:48 ET AISWEI glänzt auf der SNEC mit wegweisenden Lösungen
anpassen, wenn sie gemeinsam mit ihren Kunden wachsen. Im Bereich der Großkraftwerke stellte AISWEI die dreiphasigen PV inverter ASW 250-360kW HT series vor. Dieses Produkt ist mit den neuesten technologischen Errungenschaften von AISWEI der letzten Jahre ausgestattet und ist ähnlichen Produkten
More news about: AISWEI Technology Co., Ltd
Jun 24, 2025, 10:46 ET AISWEI brilla en SNEC con sus soluciones pioneras
En lo que respecta a las centrales eléctricas de escala comercial, AISWEI presentó el inversor fotovoltaico trifásico ASW 250-360kW serie HT. Este producto está equipado con los últimos logros tecnológicos de AISWEI de los últimos años y está por delante de productos similares. Las
More news about: AISWEI Technology Co., Ltd
Jun 24, 2025, 10:36 ET Hoth Therapeutics HT-001 Interim Results First-in-Class Topical Therapy Preserves Cancer Treatment While Resolving Dermatologic Side Effects
Therapeutics' HT-001 Achieves 100% Response Rate in at least one endpoint in Phase 2a Trial in PK Patients for EGFR Inhibitor-Related Skin Toxicities. Hoth Therapeutics will host a Key Opinion Leader (KOL) event on, at 3:30PM EST to highlight recent clinical progress with HT-001, a novel topical
More news about: Hoth Therapeutics, Inc.
Jun 24, 2025, 02:17 ET AISWEI Shines at SNEC with Pioneering Solutions
and adapt to the rhythm of the times." With regards to utility scale power plants, AISWEI presented the three-phase PV inverter ASW 250-360kW HT series. This product is equipped with the latest technological achievements of AISWEI in recent years and is ahead of similar products. AISWEI's
More news about: AISWEI Technology Co., Ltd
Jun 23, 2025, 08:03 ET Hoth Therapeutics to host KOL Event Spotlighting HT-001, Novel Therapy
(KOL) event on June 24, 2025, at 3:30PM EST to highlight recent clinical progress with HT-001, a novel topical therapeutic developed to address EGFR inhibitor-induced skin toxicities in cancer patients. This event will feature insights from derm-oncology
More news about: Hoth Therapeutics, Inc.
Jun 20, 2025, 08:00 ET Hankook Tire Launches iON HT Tire for Electric Light-Duty Trucks
highway-terrain tire designed for electric light-duty trucks - iON HT offers high-load support, ultra-low rolling resistance, and an 80K limited treadwear warranty - iON HT on display for the first time at the 2025 Electrify Expo in Los
More news about: Hankook Tire America Corp.
Jun 18, 2025, 08:22 ET Hoth Therapeutics Reports Positive Preclinical Safety Data for Cancer Fighting HT-KIT -- Dose-Dependent Liver Activity with No Observed Toxicity Supports IND Pathway
HOTH ALERT: Hoth Therapeutics Reports Positive Preclinical Safety Data for HT-KIT — Dose-Dependent Activity, No Toxicity, IND on Deck HOTH announces strong preclinical data for HT-KIT showing dose-dependent liver activity with zero observed toxicity – key milestone
More news about: Hoth Therapeutics, Inc.
Jun 17, 2025, 10:45 ET Bioprocessing Equipment Market to Reach USD 162.2 Billion by 2035, Says Meticulous Research®
Eppendorf SE, Getinge AB, Applikon Biotechnology B.V., ABEC, Inc., Solaris Biotech Solutions S.r.l., Pierre Guerin Technologies, Bioengineering AG, Infors HT, CerCell ApS, Pall Corporation (Cytiva - GE Healthcare), and Bio-Rad Laboratories, Inc. Strategic consolidation through mergers and acquisitions
More news about: Meticulous Market Research Pvt. Ltd.
Jun 17, 2025, 05:57 ET Appian France obtient la certification UGAP pour accélérer la transformation numérique des services publics français
public détient le label « Relations Fournisseurs et Achats Responsables ». En 2023, son activité globale s'est élevée à 6,67 milliards d'euros HT.
More news about: Appian
Jun 16, 2025, 08:30 ET Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
Therapeutics. "These results show that HT-4253 can be safely administered at pharmacologically active doses, positioning us to move forward into patient populations with confidence. Backed by robust preclinical data and a mechanism inspired by naturally resilient individuals, HT-4253 represents a potentially
More news about: Halia Therapeutics
Jun 16, 2025, 08:30 ET Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
Therapeutics. "These results show that HT-4253 can be safely administered at pharmacologically active doses, positioning us to move forward into patient populations with confidence. Backed by robust preclinical data and a mechanism inspired by naturally resilient individuals, HT-4253 represents a potentially
More news about: Halia Therapeutics
Jun 16, 2025, 08:08 ET Tutors International Helps Chinese Students Affected by US Visa Policy Rethink Their Academic Futures
Tutors InternationalPrama House267 Banbury RoadOxford OX2 7HTEngland Photo -
More news about: Tutors International
Jun 14, 2025, 22:28 ET AION UT estreia em Hong Kong: GAC apresenta 8 modelos emblemáticos na Feira Internacional Automotiva e de Cadeia de Suprimentos de 2025 (Hong Kong)
totalmente reclinados. O AION V, com alta qualidade, alta tecnologia e alta segurança, atende às necessidades de famílias em todo o mundo. O HYPTEC HT, um SUV elétrico, luxuoso e inteligente, apresenta uma aparência elegante e está equipado com ventilação, aquecimento e massagem nos assentos, proporcionando
More news about: GAC
Jun 14, 2025, 22:25 ET AION UT debuta en Hong Kong: GAC presenta 8 modelos emblemáticos en la Exposición Internacional de Automoción y Cadena de Suministro 2025 (Hong Kong)
posición horizontal. El AION V, con alta calidad, alta tecnología y alta seguridad, satisface las necesidades de las familias de todo el mundo. El HYPTEC HT, un SUV eléctrico lujoso e inteligente, presenta un aspecto elegante y está equipado con ventilación, calefacción y masaje en los asientos, lo que brinda
More news about: GAC
Jun 14, 2025, 22:22 ET AION UT-Debüt in Hongkong: GAC präsentiert acht Topmodelle auf der International Automotive & Supply Chain Expo 2025 (Hongkong)
umklappen. Der AION V ist mit seiner hohen Qualität, Technologie und Sicherheit auf die Bedürfnisse von Familien in aller Welt ausgerichtet. Der HYPTEC HT, ein luxuriöser und intelligenter batterieelektrischer Geländewagen, zeichnet sich durch sein elegantes Erscheinungsbild aus und ist mit Sitzbelüftung,
More news about: GAC
Jun 14, 2025, 22:14 ET AION UT fait ses débuts à Hong Kong : GAC présente huit modèles phares à l'International Automotive & Supply Chain Expo (Hong Kong) 2025
inclinés à plat. L'AION V, avec sa qualité élevée, sa haute technologie et sa sécurité renforcée, répond aux besoins des familles du monde entier. L'HYPTEC HT, un SUV électrique de luxe et intelligent, présente un design élégant et dispose de sièges ventilés, chauffants et massants pour offrir aux passagers
More news about: GAC
Jun 13, 2025, 21:33 ET "Hong Kong ACTION" Resmi Diluncurkan: Debut Global GOVY AirCab, AION UT untuk Pertama Kalinya Dilansir di Hong Kong -- GAC Awali Babak Baru dalam Ekspansi Global Bermutu Tinggi
dan keselamatan berkendara yang optimal. AION V memenuhi kebutuhan pengguna keluarga di seluruh dunia; SUV mewah, pintar, dan bertenaga listrik HYPTEC HT memiliki tampilan menarik, serta memakai kursi berventilasi, serta dilengkapi fitur pemanas dan pijat, sehingga mewujudkan pengalaman mobilitas terbaik.
More news about: GAC